CAS: 16506-27-7 - Bendamustine

Formel: C₁₆H₂₁Cl₂N₃O₂

InChl: InChI=1S/C16H21Cl2N3O2/c1-20-14-6-5-12(21(9-7-17)10-8-18)11-13(14)19-15(20)3-2-4-16(22)23/h5-6,11H,2-4,7-10H2,1H3,(H,22,23)

InChI Key: InChIKey=YTKUWDBFDASYHO-UHFFFAOYSA-N

SMILES: O=C(O)CCCC1=NC=2C=C(C=CC2N1C)N(CCCl)CCCl

Synonyme:

• 1H-Benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1-methyl-
• 2-Benzimidazolebutyric acid, 5-[bis(2-chloroethyl)amino]-1-methyl-
• 4-[5-[Bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid
• 4-{5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid
• 5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid
• ω-[1-Methyl-5-[bis(β-chloroethyl)amino]-2-benzimidazolyl]butyric acid
• Bendamustine

4-(5-(Bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid

CAS: 16506-27-7

• Formel: C₁₆H₂₁Cl₂N₃O₂
• Reinheit: %
• Farbe und Form: Solid
• Molekulargewicht: 358.2628

Bendamustine

CAS: 16506-27-7

Bendamustine (SDX105) for the treatment of Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia

• Formel: C₁₆H₂₁Cl₂N₃O₂
• Reinheit: 97.38% - ≥98%
• Farbe und Form: Solid
• Molekulargewicht: 358.26

4-(5-(Bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid

CAS: 16506-27-7

• Reinheit: 95.0%
• Molekulargewicht: 358.260009765625

Bendamustine

CAS: 16506-27-7

Applications Bendamustine is an intermediate in the synthesis of Bendamustine 3-Hydroxyprop-2-yl Ester (B132550), which is …

• Formel: C₁₆H₂₁Cl₂N₃O₂
• Farbe und Form: Neat
• Molekulargewicht: 358.263

5-(Bis(2-chloroethyl)amino)-1-methyl-2-benzimidazolebutyric acid

CAS: 16506-27-7

5-(Bis(2-chloroethyl)amino)-1-methyl-2-benzimidazolebutyric acid (BCBA) is an experimental cancer drug that is being investigated for the treatment …

• Formel: C₁₆H₂₁Cl₂N₃O₂
• Reinheit: Min. 95%
• Molekulargewicht: 358.26 g/mol